Melatonin Attenuates Calcium Deposition from Vascular Smooth Muscle Cells by Activating Mitochondrial Fusion and Mitophagy Via an AMPK/OPA1 Signaling Pathway
Overview
Endocrinology
Affiliations
Mitochondrial fusion/mitophagy plays a role in cardiovascular calcification. Melatonin has been shown to protect against cardiovascular disease. This study sought to explore whether melatonin attenuates vascular calcification by regulating mitochondrial fusion/mitophagy via the AMP-activated protein kinase/optic atrophy 1 (AMPK/OPA1) signaling pathway. The effects of melatonin on vascular calcification were investigated in vascular smooth muscle cells (VSMCs). Calcium deposits were visualized by Alizarin Red S staining, while calcium content and alkaline phosphatase (ALP) activity were used to evaluate osteogenic differentiation. Western blots were used to measure expression of runt-related transcription factor 2 (Runx2), mitofusin 2 (Mfn2), mito-light chain 3 (mito-LC3) II, and cleaved caspase 3. Melatonin markedly reduced calcium deposition and ALP activity. Runx2 and cleaved caspase 3 were downregulated in response to melatonin, whereas Mfn2 and mito-LC3II were enhanced and accompanied by decreased mitochondrial superoxide levels. Melatonin also maintained mitochondrial function and promoted mitochondrial fusion/mitophagy via the OPA1 pathway. However, OPA1 deletion abolished the protective effects of melatonin on VSMC calcification. Melatonin treatment significantly increased p-AMPK and OPA1 protein expression, whereas treatment with compound C ablated the observed benefits of melatonin treatment. Collectively, our results demonstrate that melatonin protects VSMCs against calcification by promoting mitochondrial fusion/mitophagy via the AMPK/OPA1 pathway.
Melatonin regulates mitochondrial dynamics and mitophagy: Cardiovascular protection.
Rahmani S, Roohbakhsh A, Pourbarkhordar V, Wallace Hayes A, Karimi G J Cell Mol Med. 2024; 28(18):e70074.
PMID: 39333694 PMC: 11436317. DOI: 10.1111/jcmm.70074.
Wang D, Li Q, Xie C Exp Ther Med. 2024; 28(5):419.
PMID: 39301258 PMC: 11411399. DOI: 10.3892/etm.2024.12708.
Huang J, Hao J, Wang P, Xu Y Kidney Int Rep. 2024; 9(9):2596-2607.
PMID: 39291213 PMC: 11403042. DOI: 10.1016/j.ekir.2024.05.005.
Targeting mitochondrial dynamics and redox regulation in cardiovascular diseases.
Beg M, Huang M, Vick L, Rao K, Zhang J, Chen Y Trends Pharmacol Sci. 2024; 45(4):290-303.
PMID: 38458847 PMC: 11837222. DOI: 10.1016/j.tips.2024.02.001.
Shi L, Hao M, Qu G, Xu Y, Cui Z, Geng L Balkan Med J. 2023; 41(1):54-63.
PMID: 37953594 PMC: 10767783. DOI: 10.4274/balkanmedj.galenos.2023.2023-8-44.